Related Experiment Video
Updated: Feb 27, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome
Céline Bar1, Gwenaelle Diene1,2, Catherine Molinas1,2,3
1Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, 330, avenue de Grande-Bretagne, TSA 40031 - 31059, Toulouse cedex 9, France.
Insights
Prader-Willi syndrome (PWS) affects 1 in 21,000 births in France, with many infants facing delayed diagnosis. Early detection and optimized neonatal care are crucial for managing this genetic disorder.
Area of Science:
- Genetics
- Neonatal Medicine
- Neurodevelopmental Disorders
Background:
- Prader-Willi syndrome (PWS) is a severe genetic disorder impacting neurodevelopment.
- Diagnosis typically occurs in the neonatal period due to hypotonia and feeding issues.
Purpose of the Study:
- To analyze the birth incidence of PWS in France.
- To evaluate the care of infants diagnosed with PWS early in life.
Main Methods:
- Data collected on 61 infants with molecularly confirmed PWS born in 2012-2013 in France.
- Analysis of diagnostic timelines, clinical care, and birth incidence.
Main Results:
- The 2013 birth incidence of PWS was 1/21,000.
- Median age at diagnosis was 18 days; 5 infants experienced delayed diagnosis.
- Most neonates required hospitalization (93%) and nasogastric tube feeding (84%).
Conclusions:
- This study establishes the birth incidence of PWS in France.
- Diagnostic delays occur due to unrecognized signs and suboptimal molecular testing.
- There is a need to optimize neonatal care for infants with PWS.
Background:
PWS is a severe neurodevelopmental genetic disorder now usually diagnosed in the neonatal period from hypotonia and feeding difficulties. Our study analyzed the birth incidence and care of infants with early diagnosis.
Methods:
Data were collected on 61 infants with a molecular diagnosis of PWS born in 2012 and 2013 in France.
Results:
Thirty-eight infants with PWS were born in 2013. The median age at diagnosis was 18 days. Birth incidence calculated for 2013 was 1/21,000 births. No case was diagnosed prenatally, despite 9 amniocenteses, including 4 for polyhydramnios. Five infants had delayed diagnosis, after 3 months of life. For 2 of them, the diagnosis was not suspected at birth and for 3, FISH analysis in the neonatal period was normal, with no further molecular studies. Ninety-three percent of the neonates were hospitalized, and 84% needed nasogastric tube feeding for a median of 38 days. Swallowing assessment was performed for 45%, at a median age of 10 days. Physiotherapy was started for 76% during hospitalization. Eighty percent of those diagnosed within the first 3 months were seen by a pediatric endocrinologist within the first week of life.
Conclusion:
Our study is the first to assess the birth incidence of PWS in France, at 1/21,000 births. Some prenatal or neonatal cases remain undiagnosed because of unrecognized clinical signs and the inappropriate choice of the initial molecular test. We also underscore the need to optimize neonatal care of infants with PWS.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Preventive Healthcare Services